In this review, we comprehensively examine the immune-inflammatory mechanisms associated with the cGAS–STING signaling pathway and explore a range of potential therapeutic strategies for T2DM and its cardiovascular complications. This evidence concerns the gene CGAS and type 2 diabetes mellitus.